Market intelligence for life science
Who is doing what in life science.
Every trial, paper, partnership and approval, joined to the companies, labs and people behind it, with a link to the source on every line.
Market Maps
One field per map: the trials, labs, companies and approvals in it, each linked to its source. Access is currently invite only.
Cell therapy
Every immune cell therapy trial (CAR-T, CAR-NK, NK, TIL, TCR-T and other adoptive cell therapies), the centers that run them, the companies behind them and every FDA approval.
Gene therapy
Every gene therapy trial (AAV, lentiviral and other vectors, gene editing, oncolytic viruses), the vectors behind them, the centers that run them and all 23 FDA approvals.
Spatial biology
Where spatial biology is done: papers mapped to the lab behind them, the platform each lab uses, and the core facilities that offer it.
AI in life science
Companies, startups and grant-funded groups applying AI in life science, grouped by how they use it, with the models they build and their funding.
New Approach Methodologies
From 18,031 publications, 2019 to 2026: organoids, organ-on-a-chip, spheroids, advanced 2D culture, iPSC-derived models, bioprinted tissue and in silico, each read for what the work was for.
Want a map of your own field?
Request a custom atlas →
What we do
Commission a map of your own field, plug the data into your own AI, or bring us a decision. All three are built on the same connected, sourced record as the atlases.
A market map of your field
The published atlases are the ones we chose. The same build runs on any field you name: a modality, a platform, an indication, a tool category, a competitor set. You get the map, the readouts and the directory, with a source on every line.
- Your field, your segments, your definition of the market
- A written report alongside the map
- Refreshed on a schedule, or built once
An Evidence Engine for Life Sciences
The connected graph behind the atlases (deals, companies, trials, papers, funding), delivered as an API and a connector your own AI can query, with sources attached.
- Claude, ChatGPT and Microsoft Copilot connectors
- A private knowledge base: your data plus the public record, for R&D plans, market intel, positioning and customer mapping
- Where the field is moving: market and scientific trends
- Custom reports
Product & commercial strategy
For life-science tools, diagnostics and biotech teams: product and commercial strategy, R&D decisions, market landscapes, competitive and acquirer analysis, launch and go-to-market, built on the data rather than opinion.
- Landscapes and target lists
- Positioning and launch plans
Every line has a receipt
Most market data asks you to trust the analyst. Here every trial, deal, approval and paper links to its primary source, so you can check it in one click and quote it with confidence.
"MD Anderson is a site in 297 cell therapy trials, more than any other center."
Contact
Abe Couse
I’ve spent my career launching and marketing life-science products. Now I build the evidence layer to inform those decisions, and we use it with clients: landscapes, positioning, partnering and launch for life-science tools and therapeutics companies.
Bring us a question you need answered or a decision you’re facing, and we’ll collect the data and build the analysis around it.